<strong>Background: </strong>Eyes are one of the most important facial features, their appearance being associated with state of mind, age and beauty. Therefore, upper blepharoplasty is one of the most com...<strong>Background: </strong>Eyes are one of the most important facial features, their appearance being associated with state of mind, age and beauty. Therefore, upper blepharoplasty is one of the most common procedures performed in plastic surgery. Standardized tools allow for measurement of outcomes through patient satisfaction and surgeon experience. <strong>Objectives: </strong>Our objective was to measure the satisfaction index and scar quality of patients who underwent upper blepharoplasty using the Patient-reported Outcome Measure Questionnaire (PROM-Q) and Patient and Observer Scar Assessment Scale (POSAS). <strong>Methods: </strong>A retrospective review of patients that underwent upper blepharoplasty in our institution was performed. We included those with a preoperative anthropometric analysis, standardized incision markings (developed in our center), same operative technique and a 3-month postoperative evaluation with PROM-Q and POSAS. The sample for this study consists of 67 patients, all of them operated between January 1 2019 and June 30 2019 at the Department of Plastic Surgery, South Central High Specialty Hospital, Pemex, Mexico City, Mexico. <strong>Results: </strong>A total of 67 patients were included, 73% female and 27% male. The most frequent indication for surgery was functional visual symptoms. The index of PROM-Q at 3 months demonstrated an increased satisfaction above 90%, and the evaluation with POSAS reported an almost imperceptible scar. <strong>Conclusion:</strong> Evaluating outcomes with objective tools provides data useful to improve the surgical protocols of patients subjecting to aesthetic procedures.展开更多
目的利用人工智能建立临床实验室生化检验结果自动审核系统,并评估其应用价值。方法收集2017年12月至2018年3月,52006份临床生化标本,依据美国临床实验室标准化协会(Clinical and Laboratory Standards Institude,CLSI)文件AUTO10-A-《...目的利用人工智能建立临床实验室生化检验结果自动审核系统,并评估其应用价值。方法收集2017年12月至2018年3月,52006份临床生化标本,依据美国临床实验室标准化协会(Clinical and Laboratory Standards Institude,CLSI)文件AUTO10-A-《临床检验项目结果自动验证:验收导则》和ISO(International Standards Organization)15189:2012认可准则,制定临床生化检验项目自动审核流程及规则,整合自动化流水线检测系统、流水线中间体软件、实验室信息系统(Laboratory Information System,LIS)和医院信息系统(Hospital Information System,HIS),建立自动审核系统。审核规则包括项目审核允许范围、历史结果比对允许范围、关联性逻辑判断、一致性及阴阳性结果转化判断等。2018年7月至2018年11月,对65769份临床生化标本统计、分析、评价自动审核系统应用后进行质量指标的验证并改进。结果建立了临床生化检验结果自动审核系统,对27个生化项目执行了自动审核,通过率最高的是钙、氯、总蛋白,分别为97.48%、93.52%、91.14%;通过率最低的是胆固醇、低密度脂蛋白、血糖、尿素,分别为71.54%、71.86%、75.81%、76.39%;自动审核单项平均通过率为83.53%,门急诊样本整体通过率为45%;TAT时间由125 min缩短到79 min,缩短了36.8%;审核人员由3名缩减至1名。结论建立的自动审核系统适用于临床生化项目的自动审核,借助自动审核系统可缩短TAT时间,提高检验人员工作效率。展开更多
文摘<strong>Background: </strong>Eyes are one of the most important facial features, their appearance being associated with state of mind, age and beauty. Therefore, upper blepharoplasty is one of the most common procedures performed in plastic surgery. Standardized tools allow for measurement of outcomes through patient satisfaction and surgeon experience. <strong>Objectives: </strong>Our objective was to measure the satisfaction index and scar quality of patients who underwent upper blepharoplasty using the Patient-reported Outcome Measure Questionnaire (PROM-Q) and Patient and Observer Scar Assessment Scale (POSAS). <strong>Methods: </strong>A retrospective review of patients that underwent upper blepharoplasty in our institution was performed. We included those with a preoperative anthropometric analysis, standardized incision markings (developed in our center), same operative technique and a 3-month postoperative evaluation with PROM-Q and POSAS. The sample for this study consists of 67 patients, all of them operated between January 1 2019 and June 30 2019 at the Department of Plastic Surgery, South Central High Specialty Hospital, Pemex, Mexico City, Mexico. <strong>Results: </strong>A total of 67 patients were included, 73% female and 27% male. The most frequent indication for surgery was functional visual symptoms. The index of PROM-Q at 3 months demonstrated an increased satisfaction above 90%, and the evaluation with POSAS reported an almost imperceptible scar. <strong>Conclusion:</strong> Evaluating outcomes with objective tools provides data useful to improve the surgical protocols of patients subjecting to aesthetic procedures.
文摘目的利用人工智能建立临床实验室生化检验结果自动审核系统,并评估其应用价值。方法收集2017年12月至2018年3月,52006份临床生化标本,依据美国临床实验室标准化协会(Clinical and Laboratory Standards Institude,CLSI)文件AUTO10-A-《临床检验项目结果自动验证:验收导则》和ISO(International Standards Organization)15189:2012认可准则,制定临床生化检验项目自动审核流程及规则,整合自动化流水线检测系统、流水线中间体软件、实验室信息系统(Laboratory Information System,LIS)和医院信息系统(Hospital Information System,HIS),建立自动审核系统。审核规则包括项目审核允许范围、历史结果比对允许范围、关联性逻辑判断、一致性及阴阳性结果转化判断等。2018年7月至2018年11月,对65769份临床生化标本统计、分析、评价自动审核系统应用后进行质量指标的验证并改进。结果建立了临床生化检验结果自动审核系统,对27个生化项目执行了自动审核,通过率最高的是钙、氯、总蛋白,分别为97.48%、93.52%、91.14%;通过率最低的是胆固醇、低密度脂蛋白、血糖、尿素,分别为71.54%、71.86%、75.81%、76.39%;自动审核单项平均通过率为83.53%,门急诊样本整体通过率为45%;TAT时间由125 min缩短到79 min,缩短了36.8%;审核人员由3名缩减至1名。结论建立的自动审核系统适用于临床生化项目的自动审核,借助自动审核系统可缩短TAT时间,提高检验人员工作效率。